Latest filing published 20 Oct 2026 for CYTOKINETICS INC, €915k.
No signal scores available.
Fady Malik discloses dealings in Cytokinetics Inc to SEC (Form 4). In total, 2 filings cover trades dated from 7 July 2026 to 20 October 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 20 October 2026, the filings show a transaction worth €915k in Cytokinetics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations